7 ms·
Strong placebo response thwarts painkiller trials, but only in US
- jtokoph 11y agoHmm. What if It's just that more Americans are complaining about pain that isn't truly real? Like somewhat imagined. So now a higher ratio of trial patients aren't I'll in the first place.
- GordonS 11y agoA valid question, but it raises another question - why just Americans?
- stanley 11y agoCoping mechanism for socioeconomic factors not unique to but most prominent in the US.
- dagw 11y agoWatching TV in America is nothing but a continuous flow of commercials about symptoms and diseases that they really want to convince you that you probably have. We know advertising can make you want all kinds of things, so why not symptoms and diseases?
- cristianpascu 11y agoFunny fact, any commercial for a drug, here in Romania, is ending with a very fast auction-style warning that last less than 5 seconds. In US you have like 5 minutes of country music and elder people having a picknic while all the possible dangers in the world are softly planted in your mind. :)
- DanBC 11y agoThere are a bunch of illnesses that have real pain and suffering as a symptom, but don't have any identifiable cause. Pain is sometimes one of these. The pain the person reports is real pain - you can do scans and see it - but it doesn't have a physical cause. It's likely that these people experience strong place o responses. But the. We know that cognitive behaviour therapy is used for cancer patients, and we wouldn't normally describe their pain as psychological. So, pain is complex and fascinating and difficult.
- austinjp 11y agoAbsolutely. Try answering the question "what is pain" to see how complex this phenomenon is.
- bigbugbag 11y agoWell that would explain why placebo is also rising against antidepressants, unless more American are diagnosed with being depressed than they truly are.
- DanBC 11y agoThe criteria for "major depression" have been broadened, so more people are included. Here's a recent paper talking about placebo and anti-depressants. http://onlinelibrary.wiley.com/doi/10.1002/wps.20241/abstract http://onlinelibrary.wiley.com/doi/10.1002/wps.20241/abstrac...
- lovemenot 11y agoWhy are placebos becoming increasingly effective only in the US ? A couple of hypotheses were mentioned in the article. One is that only in USA and New Zealand is direct-to-consumer drug advertising allowed. Another, which seems to have some supporting evidence, is that size and length of the drug trial may boost the placebo effect. The latter point is presumably about the production value of the trial, mandated by increasingly stringent FDA regulations. The apparent cost sells the apparent effectiveness. I wonder whether these results might be linked to USians sustained high level of religiosity, which is also unique in the developed world.
- hugh4 11y agoThe worst part is that now the news is out that placebos are getting more powerful, people are expecting it. The effect will grow exponentially. Wait, I guess that's not really bad.
- cristianpascu 11y agoA friend of mine said that placebo is very effective in Romania (our country) too. I may mistake it, but she said that it can reach something like 70-80%. Maybe it's a developing countries problem. :)
- corin_ 11y agoI'm not sure if I'm missing something either about statistics or about how the trials work, so maybe someone can enlighten me: > Based on patients’ ratings of their pain, the effect of trialled drugs in relieving symptoms stayed the same over the 23-year period — but placebo responses rose. In 1996, patients in clinical trials reported that drugs relieved their pain by 27% more than did a placebo. But by 2013, that gap had slipped to just 9%. Wouldn't an easier way to look at it be to completely ignore the effects of the actual drugs in those trials, and just look at the data of how many people took placebos and to what extent those people reported changes?
- lovemenot 11y agoI have no insight, but looking at the text you highlighted, I expect they must have done exactly the analysis you suggest. It is likely that the researchers and the audience want to understand how to get more effective drugs onto the market more than why placebos per se are becoming relatively more effective. This may explain the unexpected reporting emphasis.
- pdpi 11y agoWhen you're doing a regular drug trial, you control using a placebo to account for the effect of just taking something. In this reverse analysis you need the opposite: if the placebo effect is changing, that could either be because the placebo itself is more effective, or because people are reporting pain differently, or a number of other confounding factors. Analysing the people who took real painkillers too gives you a baseline to compare against.
- Phemist 11y agoIt's impossible to test "absolute" effects of drugs, so they are always tested in relation to each-other, this makes analysis easy because the only variable that's different is between whether participants are taking the actual drug, or a placebo. What you're suggesting would require testing a placebo in relation to not taking anything, which would introduce a lot more variables, and would make it impossible to do double-blind testing.
- 11y ago
- Phemist 11y agoThere are several problems with double-blind testing that have become apparent in the last few years, and that call for a new standard testing procedure. Double-blind rests, among others, on the assumption that a) placebo effects are independent of and additive with actual drug-effects, b) placebo effects are nulled when participants know they're being given a placebo. Although I'm currently without sources (hopefully I can rectify this soon) both a and b are actually false. Certain drugs have been found to interact with placebo, which decreases or enhances their effects, thus again conflating the medicative effects of the drugs being administered and the effects of actually taking a pill (or rather going through the process of administering medication). Second, placebo has become such a household term, that the original meaning as a "fake" effect, seems to have been lost. Logically this makes sense, because its the end result that matters (being cured), not the way in which the drug is effective (placebo or not). The average person being told they're receiving a placebo can actually increase the placebo effect, rather than nulling it. A second variable should be introduced in double-blind studies, to account for both factors I mentioned above. Variable 1 should be whether or not they're receiving the actual drug (1a) or a placebo drug (1b) (as double-blind currently tests for) and variable 2 should be whether participants are told that they're receiving the actual drug (2a), or a placebo drug (2b). Testing the effects of combination 1a/2b vs 1b/2a should test whether the drug actually interacts with a placebo effect. Providing a measure of validity for the 1a/2a vs 1b/2a test. EDIT: Fixed some spelling mistakes EDIT2: Found some sources: Guardian article on how placebo can be enhanced when participants know they're being given a placebo: http://www.theguardian.com/science/2010/dec/22/placebo-effect-patients-sham-drug http://www.theguardian.com/science/2010/dec/22/placebo-effec... Published paper that used the set-up I suggested to find caffeine-placebo interaction effects - http://www.ncbi.nlm.nih.gov/pubmed/21092089 http://www.ncbi.nlm.nih.gov/pubmed/21092089 EDIT3: This is the paper I remember reading on the subject - http://www.ncbi.nlm.nih.gov/pubmed/24416197 http://www.ncbi.nlm.nih.gov/pubmed/24416197
- Phemist 11y agoThis is, ofcourse, all based on whether a proper inert replacement for the drug-to-be-tested has been found.
- heliumcraft 11y ago
- marincounty 11y agoWhole lot of speculation in this article. I would guess more people know about the placebo effect in the U.S., than they did 20 years ago? Twenty years ago, we didn't question the efficacy of these drugs? Everyone I know now is very leery of any claims by drug companies, and their Wonder Drug. "For companies trying to develop treatments, one remedy might be to compare new drugs against their best competitors instead of against placebo — or to go back to conducting smaller, shorter trials." Lets Not do this. Lets continue to look for drugs that actually work on pain. The last thing we need is another drug that works slightly better than an ineffective pain drug that squeaked past the FDA? In the mean time there's a whole bunch of patients who are in extreme pain, and doctors are afraid to prescribe opioids. Doctors know opioid type medications work, but are afraid to prescribe them for a lot of reason, but mainly they don't want the FDA breathing down their backs. My best friend died a horrid natural death a few years ago. He was in bad shape, but the doctors couldn't find anything really wrong with him besides being very old, and had a very bad case COPD. He was in constant daily pain. I bought him to "the best pain clinic in San Francisco". They wouldn't alleviate his pain? They offed to cut some nerve, but wouldn't medicate him. (To that clinic, if you are going to stereotype patients, and offer no help--Close down? You are of no service to anyone.) I brought him back to his apartment, and offered my support every night. All I could do is cook for him, and offer hope. He died in his sleep a few months later. Those few months he were hell. All he had was ibuprofen, and some other safe/no potential to abuse drug. We looked into Hospice, but his doctors said he wasn't sick enough. Sometimes I think they have just seen too much, and common sense is lost? My point is I have seen too many people die in extreme pain, including my father who was under medicated by Hospice. I got off track. This is about painkiller trials, and placebo. I just don't want ineffective pain medication on the market. I am shocked this group of researchers are trying to blame patients. It's your ineffective new medications? Lets not run off to some third world country and get "positive" results, or rely on a bunch of smaller studies that can be buried--if not satisfactory?. (By the way, this is going on as we speak, and has been for years. They offshore these double blind studies to the lowest bidder, and surprise, "Our drug worked better than we could have predicted!". Present their wonder drug to the FDA, and start the Marketing Party. Right now, a drug only has to be slightly better than placebo in order to get past the FDA. That statistical difference is so small, in so many instances; I think if some of you knew just how slightly your drug works better than placebo, you might just go off the medication. MY father died 11 years ago, and I still have weekly nightmares of his absolute misery. His last words to me were "Son when will this end?". If I could do it over, I would have gone to the bad part of my county, and bought him Heroin.
- JumpCrisscross 11y ago> USians Out of curiosity, where are you from?
- sdrothrock 11y agoThis is the second time recently that I've seen this demonym... it's really confusing. https://news.ycombinator.com/item?id=10288270 https://news.ycombinator.com/item?id=10288270
- kragen 11y agoThere isn't really a good alternative. "Americans" doesn't work; Simón Bolívar went to war to liberate "the Americans" from the Spanish. I'm surrounded by Americans here in Buenos Aires. But almost none of them are USians. And no, I don't know how to pronounce "USian" either.
- matt4077 11y ago"Yankee" :)
- kragen 11y agoThat works everywhere except the Southeastern US, where people will be offended by it.
- maxerickson 11y agoWould they, when speaking English, self identify as "Americans"? I feel like the ambiguity exists only in some pedantic formal sense, that in colloquial usage it's clear enough what is meant.
- wodenokoto 11y agoI completely agree. In colloquial English, "An American" is someone from the United States. I don't think I ever heard anyone from outside the US being referred to as "an American"
- andy_ppp 11y agoIf you double the amount of placebos people take do they get better twice as fast? A placebo placebo trial if you will. But what would you use as a control? ;-)
- gus_massa 11y agoWere they using the same placebo? Perhaps 20 years ago they used a inert placebo, like (a sugar pill) and now they use an active placebo that mimic the side effects of the drug (for example, heartburn and indigestion). Both are placebos, but may have changed the supposed inert drug.
- ForkFed 11y agoWhy not use psychological methods in the first place, if placebo is that successful? B/c people will rather eat pills to loose weight then to eat more vegetables and do some sports ...
- austinjp 11y agoPlacebo is highly sensitive to trial design, which is what I suspect is happening here. This is an intriguing effect, meaning that trials are increasingly reporting that all sorts of therapeutic effects are apparently less effective than previously thought. Or are they? More on this at the excellent Mind Hacks blog: http://mindhacks.com/2015/07/08/cbt-is-becoming-less-effective-like-everything-else/ http://mindhacks.com/2015/07/08/cbt-is-becoming-less-effecti...